Biohaven stock rises following FDA review and Deutsche Bank's buy rating
Shares of Biohaven Ltd. (NYSE: BHVN) climbed 7% as the company announced the FDA's acceptance and Priority Review of its ...
FDA approves first new type of pain medication in 25 years
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...
STAT28d
How the FDA’s new nutrition labels could prod the food industry to get healthier
The FDA says the ratings could incentivize manufacturers to reduce levels of those three nutrients, although that’s not the agency’s goal in proposing the change. “We assume there may be ...
Positive Trial Data and FDA Prospects Drive Buy Rating for Artivion
Stifel Nicolaus analyst Rick Wise has maintained their bullish stance on AORT stock, giving a Buy rating yesterday.Invest with Confidence: ...
Buy Rating for Vertex Pharmaceuticals: FDA Approval of Journavx Boosts Market Potential and Stock Price Target
Analyst Andrew Fein of H.C. Wainwright maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), boosting the price target to ...
MPR8d
Journavx, a Nonopioid Oral Pain Medication, Gets FDA Approval
The Food and Drug Administration (FDA) has approved Journavx™ (suzetrigine) for the treatment of moderate to severe acute pain in adults.
9NEWS28d
FDA proposes mandatory nutrition labels on the front of packages
WASHINGTON — The Food and Drug Administration proposed new rules ... might reformulate products to achieve better nutrition ratings. The proposal is part of the White House National Strategy ...
HealthDay on MSN13d
FDA Approves Ozempic to Protect Kidneys in Patients With Type 2 Diabetes
WEDNESDAY, Jan. 29, 2025 (HealthDay News) -- A popular diabetes drug just got a major new approval -- and it could be a ...
Popular Science21d
FDA approves first-of-its-kind nasal spray for severe depression
The FDA fast-tracked Spravato’s approval through ... used 10-question survey known as the Montgomery-Asberg Depression Rating Scale before and after the 28-day trial to contextualize their ...
UPI21d
FDA approves Spravato, first monotherapy nasal spray to treat depression
Advertisement The FDA approval of Spravato comes after a controlled study showed the nasal spray provided rapid improvement in the Montgomery-Asberg Depression Rating Scale, when compared with a ...